CATALAYER NEWS
RallyBio tries again for reverse merger, this time with Avenzo
Source: BioPharma Dive · 2026-06-02
Full article text is available in the Catalayer news terminal.
MORE FROM BIOPHARMA DIVE
Argenx to acquire Forte in $2.2B deal for ‘differentiated’ immune drug
2026-07-28
RELATED ON CATALAYER
RELATED MARKETS
Prediction Markets